-+ 0.00%
-+ 0.00%
-+ 0.00%

Leerink Partners Maintains Outperform on CVS Health, Lowers Price Target to $112

Benzinga·10/12/2026 13:01:02
Diffusion vocale
Leerink Partners analyst Michael Cherny maintains CVS Health (NYSE:CVS) with a Outperform and lowers the price target from $119 to $112.